ES554284A0 - Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona. - Google Patents

Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.

Info

Publication number
ES554284A0
ES554284A0 ES554284A ES554284A ES554284A0 ES 554284 A0 ES554284 A0 ES 554284A0 ES 554284 A ES554284 A ES 554284A ES 554284 A ES554284 A ES 554284A ES 554284 A0 ES554284 A0 ES 554284A0
Authority
ES
Spain
Prior art keywords
benzoisotiazol
azapiro
decano
diona
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554284A
Other languages
English (en)
Other versions
ES8708228A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES554284A0 publication Critical patent/ES554284A0/es
Publication of ES8708228A1 publication Critical patent/ES8708228A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES554284A 1985-04-24 1986-04-23 Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona. Expired ES8708228A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/726,449 US4656173A (en) 1985-04-24 1985-04-24 Antipsychotic benzisothiazole S-oxide compound

Publications (2)

Publication Number Publication Date
ES554284A0 true ES554284A0 (es) 1987-10-01
ES8708228A1 ES8708228A1 (es) 1987-10-01

Family

ID=24918649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554284A Expired ES8708228A1 (es) 1985-04-24 1986-04-23 Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.

Country Status (26)

Country Link
US (1) US4656173A (es)
JP (1) JPH0764842B2 (es)
KR (1) KR900000372B1 (es)
CN (1) CN1017528B (es)
AT (1) AT394719B (es)
AU (1) AU592787B2 (es)
BE (1) BE904662A (es)
CA (1) CA1247102A (es)
CH (1) CH666034A5 (es)
DE (1) DE3613739C2 (es)
DK (1) DK187686A (es)
EG (1) EG18002A (es)
ES (1) ES8708228A1 (es)
FI (1) FI84604C (es)
FR (1) FR2581064B1 (es)
GB (1) GB2174393B (es)
GR (1) GR861063B (es)
HU (1) HU195654B (es)
IE (1) IE59182B1 (es)
IT (1) IT1208600B (es)
LU (1) LU86405A1 (es)
MY (1) MY102041A (es)
NL (1) NL8601043A (es)
PT (1) PT82450B (es)
SE (1) SE462163B (es)
ZA (1) ZA861531B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US5077295A (en) * 1988-09-16 1991-12-31 Pfizer Inc. Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
CH582699A5 (es) * 1973-03-26 1976-12-15 Sandoz Ag
AT342057B (de) * 1974-04-25 1978-03-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen 3-piperazino-isochinolinen und deren salzen
FI753625A (es) * 1975-01-06 1976-07-07 Spofa Vereinigte Pharma Werke
JPS51144735A (en) * 1975-06-06 1976-12-13 Nippon Nohyaku Co Ltd A remedy for hepatic failure
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Also Published As

Publication number Publication date
PT82450B (pt) 1988-11-30
MY102041A (en) 1992-02-29
CN1017528B (zh) 1992-07-22
LU86405A1 (fr) 1986-11-05
IT8620187A0 (it) 1986-04-23
GB2174393B (en) 1989-02-01
CN86102742A (zh) 1987-02-04
SE8601883D0 (sv) 1986-04-23
GB8609932D0 (en) 1986-05-29
FI84604C (fi) 1991-12-27
CH666034A5 (de) 1988-06-30
IT1208600B (it) 1989-07-10
JPH0764842B2 (ja) 1995-07-12
KR860008174A (ko) 1986-11-12
SE8601883L (sv) 1986-10-25
GR861063B (en) 1986-09-01
AU592787B2 (en) 1990-01-25
IE59182B1 (en) 1994-01-26
GB2174393A (en) 1986-11-05
JPS61251683A (ja) 1986-11-08
ATA110486A (de) 1991-11-15
DE3613739A1 (de) 1986-11-20
DK187686D0 (da) 1986-04-23
FI861668A0 (fi) 1986-04-21
HUT42088A (en) 1987-06-29
FI84604B (fi) 1991-09-13
ZA861531B (en) 1986-10-29
BE904662A (fr) 1986-10-23
HU195654B (en) 1988-06-28
EG18002A (en) 1991-08-30
US4656173A (en) 1987-04-07
PT82450A (en) 1986-05-01
AU5612186A (en) 1986-10-30
DK187686A (da) 1986-10-25
AT394719B (de) 1992-06-10
CA1247102A (en) 1988-12-20
FR2581064B1 (fr) 1988-09-16
DE3613739C2 (de) 1993-12-09
SE462163B (sv) 1990-05-14
FI861668A (fi) 1986-10-25
NL8601043A (nl) 1986-11-17
ES8708228A1 (es) 1987-10-01
KR900000372B1 (ko) 1990-01-25
IE861083L (en) 1986-10-24
FR2581064A1 (fr) 1986-10-31

Similar Documents

Publication Publication Date Title
ES524945A0 (es) Un procedimiento para la preparacion de 1-(4-(4,4-dialquil-2,6-piperidindion-1-il)butil)piperazinas.
ES546347A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES556550A0 (es) Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES556145A0 (es) Un procedimiento para la preparacion de nuevos derivados de piperazina.
ES540151A0 (es) Un procedimiento para la preparacion de nuevos 4-dialquilaminotetrahidrobenzol (c,d) indoles 6-sustituidos.
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES541552A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES554284A0 (es) Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.
ES550829A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES557809A0 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1,4 disustituidos
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES550874A0 (es) Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos.
ES539592A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,4-dihidropiridina.
ES535966A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ES518545A0 (es) Un procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
ES549472A0 (es) Un procedimiento para preparar 1-beta-d-ribofuranosil-1,2,4-triazol-3-carboxamida.
ES510181A0 (es) "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona".
ES555761A0 (es) Un procedimiento para la preparacion de un compuesto de quinazolinona.
ES540132A0 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.
ES2021032B3 (es) Un procedimiento para preparar pirimidoindoles substituidos.
ES513953A0 (es) "un procedimiento para la preparacion de 6-(3,6-dihidro-1(2h)-piridil)primidin-3-oxidos 2,4-disubstituidos".
ES539509A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiacetona.
ES556807A0 (es) Un procedimiento para la preparacion de nuevos 11-metileno-esteroides.